GO:0009841 mitochondrial endopeptidase Clp complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009841 describes the mitochondrial endopeptidase Clp complex, a Clp-family ATP-dependent protease located in the mitochondrion.
• The complex is built around the proteolytic subunit ClpP and AAA+ chaperone/unfoldase subunits such as CLPX, which together degrade misfolded or damaged matrix proteins.
• Mitochondrial ClpP is a druggable target: hyperactivation by small molecules such as TR-107 or imipridones causes selective cancer cell lethality.
• ClpP activity is integrated with the mitochondrial stress response, including ATF4-driven transcriptional programs and mitochondrial calcium dynamics.
• Dysregulated ClpP proteolysis contributes to cancer, vascular smooth muscle phenotype control, and mitochondrial homeostasis disorders.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect Clp complex subunit-specific functions and therapeutic potential.
Description
The mitochondrial endopeptidase Clp complex (GO:0009841) is a conserved ATP-dependent protease machine that resides in the mitochondrial matrix and controls the quality of the mitochondrial proteome. It belongs to the larger Clp protease family, whose members combine a barrel-shaped proteolytic core with AAA+ unfoldase modules to recognize, unfold, and degrade substrate proteins. In mitochondria, this complex is central to protein homeostasis, stress adaptation, and metabolic regulation, and its dysfunction has been linked to cancer, cardiovascular biology, and mitochondrial disease. Because the complex is genetically tractable and pharmacologically targetable, it has become a high-interest node for both basic mitochondrial biology and therapeutic development. Researchers studying GO:0009841 need reliable models to test subunit-specific contributions, substrate selectivity, and downstream signaling, which is why CRISPR-based cell models are increasingly used in this field.
mitochondrial endopeptidase Clp complex At A Glance
| GO ID | GO:0009841 |
|---|---|
| GO term | mitochondrial endopeptidase Clp complex |
| Ontology | cellular_component |
| Synonym | none listed |
| Major function | ATP-dependent proteolysis of mitochondrial matrix proteins within a Clp-family endopeptidase complex |
| Location | Mitochondrion, primarily the mitochondrial matrix |
| Core subunits | ClpP proteolytic subunit and AAA+ chaperone/unfoldase subunits such as CLPX |
| Related processes | Mitochondrial protein quality control, stress response, calcium signaling, and metabolic regulation |
| Disease relevance | Cancer, vascular smooth muscle phenotype, and mitochondrial homeostasis disorders |
What Is GO:0009841?
GO:0009841, mitochondrial endopeptidase Clp complex, is defined in QuickGO as a Clp endopeptidase complex located in the mitochondrion. In practical terms, it is an ATP-dependent proteolytic machine in the mitochondrial compartment that uses Clp-family subunits to degrade misfolded, damaged, or regulatory proteins, thereby maintaining mitochondrial protein quality and function.
Why Is mitochondrial endopeptidase Clp complex Important in Cell Biology?
The mitochondrial endopeptidase Clp complex is important because it sits at the intersection of mitochondrial proteostasis, stress signaling, and cell fate decisions. Its proteolytic activity removes damaged or misfolded proteins and can also regulate specific substrates that influence metabolism and survival. Pharmacological or genetic manipulation of ClpP can selectively kill cancer cells, making the complex a validated anticancer target. At the same time, ClpP activity is connected to mitochondrial calcium signaling and the integrated stress response, so it shapes how cells adapt to metabolic and environmental challenges. Understanding GO:0009841 therefore has direct implications for cancer therapy, cardiovascular biology, and mitochondrial disease research.
• Maintains mitochondrial protein quality control by degrading misfolded or damaged matrix proteins.
• Supports the mitochondrial stress response and ATF4-dependent transcriptional adaptation.
• Modulates mitochondrial calcium signaling and dynamics through interactions with disaggregases such as CLPB.
• Represents a druggable vulnerability in cancer, where ClpP hyperactivation causes selective lethality.
• Controls vascular smooth muscle cell phenotype via SIRT1-dependent mechanisms.
• Contributes to mitochondrial homeostasis and is conserved from bacteria to humans.
• Provides a model system for studying AAA+ protease mechanism and substrate recognition.
• Offers a target for small-molecule agonists such as TR-107 in colorectal cancer.
• Links mitochondrial proteolysis to metabolic reprogramming and cell survival decisions.
• Enables CRISPR-based dissection of subunit-specific functions in disease models.
What Happens During mitochondrial endopeptidase Clp complex?
Substrate Recognition and Unfolding
In simple terms: The Clp complex first grabs and unfolds damaged proteins so they can be fed into the protease chamber.
In the mitochondrial Clp complex, AAA+ chaperone subunits such as CLPX recognize and bind substrate proteins, then use ATP hydrolysis to unfold and translocate them into the proteolytic core. This step ensures that only accessible, unfolded polypeptides enter the degradation chamber, providing specificity and preventing uncontrolled proteolysis.
Proteolytic Degradation in the ClpP Chamber
In simple terms: Once inside, the protein is chopped into small pieces by the ClpP protease.
The proteolytic subunit ClpP forms a barrel-shaped chamber with active sites that cleave translocated substrates into short peptides. This ATP-dependent degradation is the central catalytic event of GO:0009841 and is required for mitochondrial protein quality control.
Integration with Mitochondrial Stress Signaling
In simple terms: When mitochondria are stressed, the Clp complex helps trigger a broader cellular response.
ClpP activity is linked to the mitochondrial stress response, including ATF4-driven transcriptional programs that adapt cells to proteotoxic and metabolic stress. This integration allows the complex to influence cell fate beyond simple protein removal.
Regulation of Calcium and Dynamics
In simple terms: The Clp system also helps control calcium signals and how mitochondria move and change shape.
Recent work shows that mitochondrial calcium signaling and dynamics depend on the disaggregase CLPB, which cooperates with the Clp system to maintain mitochondrial function. This places GO:0009841 in a network that coordinates proteolysis with ion homeostasis and organelle remodeling.
Key Genes Involved in GO:0009841 mitochondrial endopeptidase Clp complex
The following genes and proteins are core components or direct regulators of the mitochondrial endopeptidase Clp complex and are commonly studied in this field.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLPP | Proteolytic subunit of the mitochondrial Clp complex | Target for cancer therapeutics and knockout studies |
| CLPX | AAA+ chaperone/unfoldase that feeds substrates to ClpP | Mechanistic studies of substrate recognition |
| CLPB | Mitochondrial disaggregase cooperating with Clp system | Links proteolysis to calcium signaling and dynamics |
| ATF4 | Transcription factor driving mitochondrial stress response | Readout of Clp-dependent stress signaling |
| SIRT1 | Deacetylase controlling VSMC phenotype downstream of ClpP | Vascular biology and ClpP inhibition studies |
| TR-107 | Small-molecule ClpP agonist (not a gene) | Pharmacological activation in colorectal cancer |
| Imipridone ONC201 | ClpP agonist used in cancer studies (not a gene) | Selective cancer cell lethality |
| mtHSP70 | Mitochondrial chaperone assisting protein folding | Functional partner in proteostasis |
| HSP60 | Mitochondrial chaperonin | Cooperates with Clp system in quality control |
| LONP1 | Mitochondrial protease | Parallel protease pathway in matrix |
| YME1L | Inner membrane protease | Comparative studies of mitochondrial proteases |
| OMA1 | Inner membrane protease | Stress-responsive protease network |
| PARL | Inner membrane protease | Mitochondrial dynamics and quality control |
| i-AAA protease | Inner membrane AAA+ protease | Comparative AAA+ mechanism studies |
| m-AAA protease | Inner membrane AAA+ protease | Comparative AAA+ mechanism studies |
| CLPP2 | Plant plastidial Clp subunit (not mitochondrial) | Comparative Clp protease biology |
How Is mitochondrial endopeptidase Clp complex Regulated?
The mitochondrial endopeptidase Clp complex is regulated at multiple levels. Its activity depends on ATP availability and the availability of AAA+ chaperone partners such as CLPX, which control substrate delivery. Transcriptionally, mitochondrial stress activates ATF4, which coordinates a broader proteostatic response that includes Clp components. Pharmacologically, small molecules such as imipridones and TR-107 can hyperactivate ClpP, overriding normal regulation and causing selective cancer cell death. In vascular smooth muscle, ClpP activity is linked to SIRT1-dependent signaling, indicating that post-translational and metabolic inputs also shape Clp complex function.
mitochondrial endopeptidase Clp complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CLPP | Cancer (selective lethality via ClpP activation) | CRISPR knockout and overexpression in cancer cell lines |
| CLPP | Vascular smooth muscle phenotype | SIRT1-dependent VSMC models with ClpP modulation |
| CLPB | Mitochondrial calcium signaling and dynamics | CLPB knockout or point-mutation cells |
| ATF4 | Mitochondrial stress response | ATF4 knockout and stress induction models |
| CLPX | Mitochondrial protein quality control | CLPX knockout and substrate profiling |
Cancer
Mitochondrial ClpP is a druggable anticancer target. Hyperactivation of ClpP by small molecules such as imipridones induces selective cancer cell lethality by disrupting mitochondrial proteostasis and metabolism. The ClpP agonist TR-107 similarly disrupts mitochondrial metabolism and inhibits the growth of human colorectal cancer cells. These findings establish GO:0009841 as a therapeutic node in oncology.
Cardiovascular Biology
ClpP controls vascular smooth muscle cell phenotype through a SIRT1-dependent mechanism, linking mitochondrial proteolysis to vascular remodeling and cardiovascular disease. This suggests that modulating Clp complex activity could influence VSMC-driven pathologies.
Mitochondrial Homeostasis Disorders
The Clp protease contributes to mitochondrial homeostasis, and its dysfunction is associated with impaired protein quality control and stress adaptation. Disruption of ClpP or its partners can compromise mitochondrial function and cellular viability under stress.
Stress and Calcium Signaling
Mitochondrial calcium signaling and dynamics depend on the disaggregase CLPB, which cooperates with the Clp system. This connection implies that Clp complex dysfunction may contribute to disorders of calcium handling and mitochondrial dynamics.
From mitochondrial endopeptidase Clp complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CLPP loss affect mitochondrial proteostasis? | CLPP knockout cell line |
| Can a point mutation in CLPP alter substrate specificity? | CLPP point-mutation knock-in |
| How does tagged CLPP localize in mitochondria? | Tagged knock-in of CLPP |
| Does CLPP overexpression sensitize cancer cells? | CLPP overexpression cell model |
| What is the role of CLPB in calcium signaling? | CLPB knockout or point-mutation cells |
| How does ATF4 mediate stress response? | ATF4 knockout with mitochondrial stress |
How to Study the mitochondrial endopeptidase Clp complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry proteomics | Protein abundance and degradation | Substrate identification for Clp complex |
| RNA-seq | Transcriptional changes | ATF4-dependent stress response |
| Live-cell calcium imaging | Mitochondrial calcium dynamics | CLPB and Clp system function |
| CRISPR knockout | Loss-of-function phenotypes | CLPP, CLPX, CLPB studies |
| CRISPR point mutation | Specific residue function | Catalytic or substrate-binding mutants |
| Tagged knock-in | Protein localization and interactions | Clp subunit imaging |
| Overexpression | Gain-of-function effects | ClpP sensitization in cancer |
| Small-molecule screening | Pharmacological sensitivity | ClpP agonist testing |
Proteomics and Substrate Profiling
Mass spectrometry-based proteomics can identify proteins that accumulate or are degraded upon Clp complex manipulation, revealing substrate specificity and pathway crosstalk. This approach is essential for defining the functional footprint of GO:0009841.
Transcriptomics and Stress Response Assays
RNA-seq and ATF4 target analysis can measure how Clp complex perturbation alters the mitochondrial stress response and downstream transcriptional programs. These methods link proteolysis to cellular adaptation.
Imaging and Calcium Dynamics
Live-cell imaging of mitochondrial calcium and morphology can assess how Clp components and partners such as CLPB influence organelle dynamics. This is particularly useful for connecting GO:0009841 to calcium signaling.
Pharmacological and Genetic Perturbation
Small-molecule ClpP agonists such as imipridones and TR-107, combined with CRISPR knockout or overexpression, allow researchers to test causality and therapeutic potential. Such integrated approaches are standard in Clp complex research.
How CRISPR Can Be Used to Study GO:0009841 mitochondrial endopeptidase Clp complex
Knockout
CRISPR knockout of CLPP, CLPX, or CLPB enables loss-of-function studies to determine which subunits are essential for mitochondrial proteostasis and stress responses. Knockout models are foundational for linking GO:0009841 to disease phenotypes.
Point Mutation
Point-mutation knock-in can dissect catalytic residues or substrate-binding sites within ClpP and its partners, revealing mechanistic details that knockout cannot provide. Such models are valuable for understanding selective proteolysis.
Knock-in
Tagged knock-in of Clp subunits allows precise localization and interaction studies in live cells, clarifying how the complex assembles and functions in mitochondria. This is critical for structural and dynamic analyses.
Overexpression
Overexpression of CLPP or its partners can mimic hyperactivation states observed with pharmacological agonists and test whether increased proteolysis drives cancer cell lethality or metabolic rewiring. Overexpression models complement knockout approaches.
How EDITGENE Supports mitochondrial endopeptidase Clp complex Research
Researchers studying mitochondrial endopeptidase Clp complex-related genes often need to determine whether a candidate gene is causally involved in mitochondrial proteostasis, stress signaling, or disease phenotypes. Rigorous causal inference requires well-controlled genetic models that isolate loss-of-function, gain-of-function, and specific residue contributions. EDITGENE provides a comprehensive suite of CRISPR services tailored to these needs, enabling reproducible and publication-ready experiments.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial endopeptidase Clp complex research.
Frequently Asked Questions About mitochondrial endopeptidase Clp complex
What is the mitochondrial endopeptidase Clp complex?
It is an ATP-dependent protease complex located in mitochondria, defined by GO:0009841, that degrades misfolded or damaged proteins to maintain mitochondrial homeostasis.
What genes are involved in the mitochondrial endopeptidase Clp complex?
Core genes include CLPP, which encodes the proteolytic subunit, and CLPX, which encodes an AAA+ chaperone that feeds substrates into ClpP.
Where is the mitochondrial endopeptidase Clp complex located?
It is located in the mitochondrion, primarily in the mitochondrial matrix.
What is the function of CLPP in mitochondria?
CLPP forms the proteolytic chamber of the Clp complex and cleaves unfolded substrate proteins in an ATP-dependent manner.
How is the Clp complex linked to cancer?
Hyperactivation of ClpP by small molecules such as imipridones or TR-107 causes selective cancer cell lethality, making it a druggable target.
What is the role of CLPB in mitochondrial function?
CLPB is a disaggregase that supports mitochondrial calcium signaling and dynamics, cooperating with the Clp system.
How does the mitochondrial stress response relate to Clp complex?
ATF4 is a key regulator of the mitochondrial stress response and is induced when Clp-dependent proteostasis is perturbed.
Can ClpP be targeted pharmacologically?
Yes, ClpP agonists such as imipridones and TR-107 have shown efficacy in cancer models by disrupting mitochondrial metabolism.
What experimental models are used to study GO:0009841?
CRISPR knockout, point-mutation, knock-in, and overexpression cell models, combined with proteomics and imaging, are commonly used.
Why is the Clp complex important for mitochondrial homeostasis?
It removes damaged proteins and regulates stress signaling, and its dysfunction contributes to cancer and mitochondrial disorders.
Conclusion
The mitochondrial endopeptidase Clp complex (GO:0009841) is a central ATP-dependent protease machine that safeguards mitochondrial protein quality and participates in stress signaling, calcium dynamics, and metabolic regulation. Its druggability in cancer and its role in vascular biology make it a high-value target for both mechanistic and translational research. CRISPR-based cell models, combined with proteomics and imaging, provide the most rigorous path to dissect subunit-specific functions and therapeutic potential. EDITGENE offers end-to-end support to accelerate discoveries in this rapidly evolving field.
References
- 1. Ishizawa J et al.. 2019. Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.. Cancer Cell 35(5):721-737.e9 PMID: 31056398
- 2. Quirós PM et al.. 2017. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals.. J Cell Biol 216(7):2027-2045 PMID: 28566324
- 3. D'Angelo D et al.. 2025. Dependence of mitochondrial calcium signalling and dynamics on the disaggregase, CLPB.. Nat Commun 16(1):2810 PMID: 40118824
- 4. Illigmann A et al.. 2021. Contribution of the Clp Protease to Bacterial Survival and Mitochondrial Homoeostasis.. Microb Physiol 31(3):260-279 PMID: 34438398
- 5. Currie SQW et al.. 2026. Molecular mechanisms of mitochondrial AAA+ proteases.. J Biol Chem 302(3):111264 PMID: 41655698
- 6. Rodriguez-Concepcion M et al.. 2019. Control of plastidial metabolism by the Clp protease complex.. J Exp Bot 70(7):2049-2058 PMID: 30576524
- 7. Paredes F et al.. 2024. The mitochondrial protease ClpP is a druggable target that controls VSMC phenotype by a SIRT1-dependent mechanism.. Redox Biol 73:103203 PMID: 38823208
- 8. Giarrizzo M et al.. 2024. TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells.. Mol Cancer Ther 23(12):1761-1778 PMID: 39233476
